NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
Active, not recruiting · NCT05825625 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-06-23 | NCT05825625 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 34 |
| Roche Pharma AG | 59 |
| Thoraxklinik-Heidelberg gGmbH | 2 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Thoraxklinik Heidelberg | Heidelberg | Germany | 5 |
| Universitätsklinikum Essen (AöR)-Westdeutsches Tumorzentrum Essen | Essen | Germany | 1 |